Precision Medicine – Changing the DNA of Health Care
How precision medicine is changing the shape of health – by Alan Trounson
Human disease is generally a consequence of complex interaction between our genes and the environment. Traditionally, medical research focuses on creating therapies to treat specific diseases.
This can be very effective and these therapies can have universal […]
For more information click the link here …..
ABC – Australian Story …..
When Newcastle radio host Jill Emberson was told she had terminal ovarian cancer, she opted to go public and go loud.
She discovered her disease was the most neglected and deadliest of all womens’ cancers and vowed to improve awareness and research funding.
Her mission took her from scientific labs, to street protests […]
Left to right : Jongmoon Kim, ToolGen CEO and Alan Trounson, Cartherics CEO shook hands and signed the papers whilst Cartherics Chairman Bob Moses looked on.
By Leigh Dayton, Cartherics […]
https://www.eradicatecancer2020.org
We are excited to announce that registrations & abstract submissions for Eradicate Cancer 2020 are now open!
The field of immunotherapy against cancers is making unprecedented progress. The Eradicate Cancer Conference “Can advanced immunotherapy make it possible?” held in March 2018 was a resounding success and the delegates have confirmed they would be there when held again. It made […]
Congratulations to Cartherics’ Scientific Advisor Jacques Miller. He co-shares the 2019 Lasker Award for medical research.
Australian scientist, Professor Jacques Miller has won the prestigious Lasker award, often referred to as “America’s Nobels”, for discovering the function […]
28 August, Sophie Laurenson, PhD
https://www.clinicallabmanager.com
Immunotherapy describes a set of therapies that leverage the capacity of the immune system to combat disease. Recent clinical successes of immunotherapies have made this an active field of research. It is considered one of the […]
5 September 2019
Using the tools of biotechnology and immunology to help transforming cancer from a fatal to a manageable — or even curable – disease holds profound benefits to individual patients and the […]
By Leigh Dayton, 2 September 2019
Cartherics has been invited to present at the prestigious Cell & Gene Meeting on the Mesa https://www.meetingonthemesa.com/ in Carlsbad, California in October. The meeting is the sector’s leading annual conference, bringing senior industry executives together with the scientific community to advance research into cell-based therapies.
The meeting covers a variety […]
CAR-T immunotherapy involves genetically engineering T-cells with chimeric antigen receptors (CARs). FLOW cytometry uses antibodies tagged with fluorescent markers that bind to specific cell receptors. The labelled cells are then fed through a series of lasers and profiled using software such as FLOWLOGIC. FLOW cytometry works to […]
Cartherics’ mission is the development of novel, immune cell therapy products for the treatment of cancer, endometriosis and Alzheimer’s disease.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd
